Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-26 Sale |
2021-05-28 4:03 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $65.37 | $108,911 | 134,089 (Direct) |
View |
| 2021-05-21 Sale |
2021-05-24 8:05 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
46,763 | $60.11 | $2,811,048 | 2,542,296 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-06 6:50 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $55.49 | $554,864 | 602,626 (Indirect Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 4:14 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
3,237 | $60.11 | $194,589 | 2,589,059 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 4:13 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
18,333 | $58.64 | $1,075,102 | 2,385,766 (Indirect Direct) |
View |
| 2021-04-28 Sale |
2021-04-30 5:07 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $62.15 | $103,538 | 135,755 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-06 8:39 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $56.09 | $560,901 | 612,626 (Indirect Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 4:10 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
50,000 | $56.62 | $2,831,071 | 2,592,296 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 4:09 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
18,334 | $56.6 | $1,037,684 | 2,404,099 (Indirect Direct) |
View |
| 2021-03-31 Sale |
2021-04-01 4:47 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $56.42 | $93,992 | 137,421 (Direct) |
View |
| 2021-03-29 Sale |
2021-03-31 6:30 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,822 | $54.62 | $154,126 | 269,701 (Indirect Direct) |
View |
| 2021-03-15 Sale |
2021-03-16 7:16 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
50,000 | $61.89 | $3,094,563 | 947,587 (Indirect Direct) |
View |
| 2021-03-04 Sale |
2021-03-04 6:38 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $61.02 | $610,171 | 622,626 (Indirect Direct) |
View |
| 2021-03-03 Sale |
2021-03-04 6:04 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $61.61 | $102,641 | 139,087 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:21 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
7,092 | $66.38 | $470,741 | 272,523 (Indirect Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:20 pm |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
100,000 | $66.22 | $6,622,207 | 2,642,296 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:19 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
18,334 | $66.35 | $1,216,551 | 2,462,433 (Indirect Direct) |
View |
| 2021-02-16 Sale |
2021-02-18 6:12 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
50,000 | $65.09 | $3,254,710 | 997,587 (Indirect Direct) |
View |
| 2021-02-12 Sale |
2021-02-17 8:39 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner |
2,216,798 | $65 | $144,091,870 | 10,084,938 (Indirect) |
View |
| 2021-02-11 Sale |
2021-02-16 7:43 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
3,156 | $70.33 | $221,972 | 279,615 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 7:43 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
3,047 | $70.35 | $214,341 | 632,626 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 7:42 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
3,035 | $70.34 | $213,480 | 1,047,587 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 7:40 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
9,473 | $70.3 | $665,984 | 2,480,767 (Indirect Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 7:13 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
1,468 | $74.8 | $109,809 | 556,530 (Indirect Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 7:11 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
1,448 | $74.68 | $108,135 | 971,479 (Indirect Direct) |
View |
| 2021-02-09 Sale |
2021-02-11 7:10 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
1,470 | $74.68 | $109,785 | 202,897 (Indirect Direct) |
View |
| 2021-02-09 Sale |
2021-02-10 7:40 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
5,112 | $73.79 | $377,211 | 2,331,453 (Indirect Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:44 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
10,000 | $67.84 | $678,361 | 545,248 (Indirect Direct) |
View |
| 2021-02-01 Sale |
2021-02-02 9:21 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
18,334 | $68.44 | $1,254,819 | 2,304,649 (Indirect) |
View |
| 2021-01-15 Sale |
2021-01-20 6:46 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
50,000 | $71.45 | $3,572,556 | 960,177 (Indirect Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 6:50 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
70,000 | $74.95 | $5,246,408 | 675,248 (Indirect Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 6:49 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
88,334 | $74.96 | $6,621,782 | 2,562,978 (Indirect Direct) |
View |
| 2020-12-21 Sale |
2020-12-23 9:52 pm |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
30,000 | $90.05 | $2,701,582 | 57,464 (Indirect Direct) |
View |
| 2020-12-11 Sale |
2020-12-15 4:47 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
64,624 | $80.14 | $5,179,285 | 12,585,045 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-09 Gift |
2021-04-05 4:09 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
40,000 | $0 | 2,404,099 (Indirect) |
View |
| 2021-02-07 Exercise |
2021-02-11 7:13 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
4,250 | $0 | 556,530 (Direct) |
View |
| 2021-02-07 Exercise |
2021-02-11 7:11 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
4,250 | $0 | 971,479 (Direct) |
View |
| 2021-02-07 Exercise |
2021-02-11 7:10 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
4,250 | $0 | 202,897 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 7:40 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
14,316 | $0 | 2,331,453 (Direct) |
View |
| 2021-01-08 Option Award |
2021-01-12 6:44 pm |
N/A 2031-01-07 |
Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director |
10,046 | $0 | 10,046 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 6:55 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 6:54 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 6:50 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
120,000 | $0 | 675,248 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 6:49 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
240,000 | $0 | 2,562,978 (Direct) |
View |
| 2020-12-21 Other |
2020-12-23 6:44 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
383,411 | $0 | 12,585,045 (Indirect) |
View |
| 2020-08-20 Exercise(A) |
2020-11-30 6:11 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
5,643 | $0 | 625,248 (Indirect) |
View |
| 2020-08-21 Tax Withholding(A) |
2020-11-30 6:11 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COO and Secretary |
1,954 | $32.88 | 625,248 (Indirect) |
View |